Medical Devices Australia

Australia Tumor Ablation Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Australia Tumor Ablation Market Industry Trends and Forecast to 2034: Segmented by (Technology, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $24.1 Mn Placeholder estimate
Estimate 2025 $27.2 Mn 1.4% of the global market
Projected 2034 $80.5 Mn 195.7% Adds $53.3 Mn over 9 forecast years
CAGR 2025–2034 12.8% Faster than 69% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.38% of the global market.
  • In APAC, the largest is China at $151.5 Mn.
  • Fastest growing: India at 14% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$53.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tumor Ablation Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $24.1 Mn — —
2025 (base) $27.2 Mn +$3.1 Mn —
2026 (forecast) $30.7 Mn +$3.5 Mn +12.8%
2027 (forecast) $34.6 Mn +$3.9 Mn +27.2%
2028 (forecast) $39.1 Mn +$4.4 Mn +43.5%
2029 (forecast) $44.1 Mn +$5.0 Mn +61.9%
2030 (forecast) $49.7 Mn +$5.6 Mn +82.6%
2031 (forecast) $56.1 Mn +$6.4 Mn +106%
2032 (forecast) $63.3 Mn +$7.2 Mn +132.4%
2033 (forecast) $71.4 Mn +$8.1 Mn +162.1%
2034 (forecast) $80.5 Mn +$9.1 Mn +195.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Tumor Ablation Market Analysis at a glance
Market size, 2025$27.2 Mn placeholder estimate
Forecast, 2034$80.5 Mn placeholder estimate
Growth (CAGR), 2025–203412.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTechnology, cancer and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Johnson & Johnson, AngioDynamics, Inc., HealthTronics (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
Active clinical trials3 in AustraliaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Tumor Ablation Market Analysis Executive Summary

Tumour ablation destroys tumours with heat, cold or electric fields through a needle, instead of open surgery.

Key segments of the tumor Ablation market include technology (Radiofrequency Ablation, Microwave Ablation and Cryoablation) and cancer (Liver, Lung and Kidney).

Bar chart: Australia Tumor Ablation market size, 2024–2034, placeholder estimates. $24.1 Mn in 2024, $27.2 Mn in 2025 and $80.5 Mn in 2034, 12.8% CAGR.
Australia Tumor Ablation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Tumor Ablation Market Dynamics

Market Growth Drivers

Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the tumor Ablation market. Faster approvals and new combinations are improving survival.

Opportunity

Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the tumor Ablation market.

Market Restraints

High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the tumor Ablation market, especially in low- and middle-income countries.

Competitive Landscape for Tumor Ablation Market in Australia

The tumor Ablation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tumor Ablation Market in Australia

Tumor Ablation in Australia: rules, payment and research

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2] ClinicalTrials.gov lists 3 studies on Tumor Ablation that are recruiting, active or about to start in Australia.⁠[3]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tumor Ablation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tumor Ablation right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tumor Ablation in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tumor Ablation market in Australia?
Placeholder estimate: about $27.2 Mn in 2025, rising to about $80.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tumor Ablation market in Australia growing?
Placeholder estimate: about 12.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tumor Ablation market report cover?
The report splits the market by technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and more), cancer (Liver, Lung, Kidney, Bone) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tumor Ablation market?
Key players include Medtronic, Boston Scientific Corporation, Johnson & Johnson, AngioDynamics, Inc. and HealthTronics.
What is driving the Tumor Ablation market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the tumor Ablation market. Faster approvals and new combinations are improving survival.
Who regulates Tumor Ablation in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How many clinical trials on Tumor Ablation are running in Australia?
3 studies are recruiting, active or about to start in Australia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Australia. Retrieved 12 Nov 2026.
How much research is published on Tumor Ablation?
PubMed lists 1,479 papers on Tumor Ablation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on oncology

See the topic